Administration of Vaginal and Rectal Progesterone During FET Cycles

Thor Haahr

Status: Completed

Conditions: Infertility

Treatments: Drug: Progesterone

Study type: Observational

Funder types: Other

Identifiers

NCT03470610

Progesterone03

Details and patient eligibility

About

Observational study of reproductive outcome after frozen embryo transfer in HRT with vaginal and rectal progesterone.

Full description

Cohort of patients treated with autologous blastocyst at the Fertility clinic Skive Regional Hospital in HRT cycle. Estradiol stimulation started on second cycle day and on day 12 - 20 vaginal and rectal progesterone is added. Blastocyst transfer on 6th progesterone treatment day. Serum progesterone and hCG measurement 9 or 11 days after embryo transfer.

Enrollment: 277 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Frozen embryo transfer cycles in HRT cycles

Exclusion criteria

• Donor frozen embryo transfer